Latest Posts › European Patent Office

Share:

Navigating Key Differences in Therapeutic Antibody Patent Protection Strategies Between the United States and Europe

Many of today’s top-selling drugs worldwide are therapeutic antibodies thus antibody-related inventions can be extremely valuable. Developing antibody therapeutics requires significant resources and time, so it is paramount...more

Late But Not Too Late | Submitting Post-Filing Data During Patent Prosecution in Selected Jurisdictions

Intellectual Property counsel often face the dilemma of when to file a patent application: as soon as possible, or wait and gather more support? Filing an application “early” helps to avoid anticipatory prior art but if the...more

European Patent Office COVID-19-Related Extension Period Ends Tuesday, June 2, 2020

We previously published an alert that the European Patent Office (EPO), had issued a Notice that extended the times to file papers that could not be filed due to disruptions caused by the COVID-19 pandemic. The EPO extended...more

Further Extensions for EPO Deadlines Available (Updated)

We previously published an alert that the European Patent Office (EPO), the European Union Intellectual Property Office (EUIPO) and United States Patent and Trademark Office (USPTO) had issued Notices that extended the times...more

Further Extensions for EPO Deadlines Available

We previously published an alert that the European Patent Office (EPO), the European Union Intellectual Property Office (EUIPO) and United States Patent and Trademark Office (USPTO) had issued Notices that extended the times...more

5 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide